These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 15817883

  • 1. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery.
    Shiga N, Hirano K, Hirano M, Nishimura J, Nawata H, Kanaide H.
    Circ Res; 2005 May 13; 96(9):1014-21. PubMed ID: 15817883
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T, Hein TW, Yoshida A, Kuo L.
    Invest Ophthalmol Vis Sci; 2007 Feb 13; 48(2):825-32. PubMed ID: 17251484
    [Abstract] [Full Text] [Related]

  • 3. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC.
    Takeuchi S, Kawashima S, Rikitake Y, Ueyama T, Inoue N, Hirata K, Yokoyama M.
    Biochem Biophys Res Commun; 2000 Mar 05; 269(1):97-102. PubMed ID: 10694484
    [Abstract] [Full Text] [Related]

  • 4. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
    Teixeira CE, Jin L, Ying Z, Palmer T, Priviero FB, Webb RC.
    Clin Exp Pharmacol Physiol; 2005 Oct 05; 32(10):817-24. PubMed ID: 16173942
    [Abstract] [Full Text] [Related]

  • 5. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension.
    Budzyn K, Marley PD, Sobey CG.
    J Pharmacol Exp Ther; 2005 Jun 05; 313(3):1248-53. PubMed ID: 15743931
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y, Kimoto K, Imaizumi M, Nakatsuka K.
    Exp Eye Res; 2007 Mar 05; 84(3):464-72. PubMed ID: 17217948
    [Abstract] [Full Text] [Related]

  • 7. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB, Teixeira CE, Toque HA, Claudino MA, Webb RC, De Nucci G, Zanesco A, Antunes E.
    Clin Exp Pharmacol Physiol; 2006 Mar 05; 33(5-6):448-55. PubMed ID: 16700877
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
    Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U.
    Circulation; 2003 Jun 24; 107(24):3081-7. PubMed ID: 12796138
    [Abstract] [Full Text] [Related]

  • 9. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
    Liu CQ, Leung FP, Wong SL, Wong WT, Lau CW, Lu L, Yao X, Yao T, Huang Y.
    Biochem Pharmacol; 2009 Aug 15; 78(4):374-81. PubMed ID: 19409373
    [Abstract] [Full Text] [Related]

  • 10. Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells.
    Yufu T, Hirano K, Bi D, Hirano M, Nishimura J, Iwamoto Y, Kanaide H.
    Arterioscler Thromb Vasc Biol; 2005 Jul 15; 25(7):1506-11. PubMed ID: 15860737
    [Abstract] [Full Text] [Related]

  • 11. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH, Cho YS, Han YM.
    Stem Cells; 2007 Jul 15; 25(7):1654-63. PubMed ID: 17464088
    [Abstract] [Full Text] [Related]

  • 12. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
    Kansui Y, Fujii K, Goto K, Oniki H, Iida M.
    Clin Exp Pharmacol Physiol; 2006 Aug 15; 33(8):673-8. PubMed ID: 16895538
    [Abstract] [Full Text] [Related]

  • 13. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
    Eto M, Rathgeb L, Cosentino F, Kozai T, Lüscher TF.
    J Cardiovasc Pharmacol; 2006 May 15; 47(5):663-7. PubMed ID: 16775505
    [Abstract] [Full Text] [Related]

  • 14. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, Lamas S.
    J Clin Invest; 1998 Jun 15; 101(12):2711-9. PubMed ID: 9637705
    [Abstract] [Full Text] [Related]

  • 15. Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism.
    Wang S, Wright G, Harrah J, Touchon R, McCumbee W, Geng W, Fultz ME, Abdul-Jalil MN, Wright GL.
    Can J Physiol Pharmacol; 2000 Jun 15; 78(6):500-6. PubMed ID: 10914640
    [Abstract] [Full Text] [Related]

  • 16. Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.
    Alvarez De Sotomayor M, Herrera MD, Marhuenda E, Andriantsitohaina R.
    Br J Pharmacol; 2000 Nov 15; 131(6):1179-87. PubMed ID: 11082126
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
    Matsuda N, Hayashi Y, Takahashi Y, Hattori Y.
    J Pharmacol Exp Ther; 2006 Dec 15; 319(3):1348-54. PubMed ID: 17003232
    [Abstract] [Full Text] [Related]

  • 19. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N, Kondo M, Ito S, Ito Y, Shimokata K, Kume H.
    Am J Respir Cell Mol Biol; 2006 Dec 15; 35(6):722-9. PubMed ID: 16858009
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.
    Löhn M, Steioff K, Bleich M, Busch AE, Ivashchenko Y.
    Eur J Pharmacol; 2005 Jan 10; 507(1-3):179-86. PubMed ID: 15659308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.